Related Experiment Video
Updated: Oct 26, 2025
13:35
Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction
Published on: May 17, 2024
3.2K
Late Campylobacter jejuni mastitis after augmentation mammoplasty
Tomas Vedin1,2, Henrik Bergenfeldt1,2
1Department of Clinical Sciences, Faculty of Medicine, Lund University, Lund, Sweden.
JPRAS Open
|August 2, 2021
Summary
Breast implant-associated infections (BIAI) can stem from uncommon bacteria like Campylobacter jejuni. Prompt diagnosis and broad-spectrum antibiotics are crucial for effective treatment when initial therapies fail.
Area of Science:
- Infectious Diseases
- Microbiology
- Plastic Surgery
Background:
- Breast implant-associated infections (BIAI) affect around 2% of patients undergoing augmentation mammoplasty.
- While conservative treatment is sometimes possible, many BIAI cases necessitate implant removal.
- Identifying less common pathogens is vital for effective BIAI management.
Observation:
- A case report details bilateral late mastitis in a 34-year-old woman caused by Campylobacter jejuni.
- The patient presented with no preceding gastrointestinal symptoms.
- This highlights a rare presentation of BIAI.
Findings:
- Campylobacter jejuni, an uncommon pathogen, was identified as the cause of BIAI.
- Standard treatment protocols may be insufficient for atypical BIAI pathogens.
- The case underscores the need for adaptable antibiotic strategies.
Implications:
- Clinicians should consider a broad range of potential pathogens in BIAI, even in the absence of typical symptoms.
- Treatment of refractory BIAI may require a switch to broad-spectrum antibiotics.
- This case expands the known spectrum of pathogens associated with breast implant infections.
